|By PR Newswire||
|September 4, 2014 07:00 AM EDT|
THE WOODLANDS, Texas, Sept. 4, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Morgan Stanley 2014 Global Healthcare Conference on Tuesday, September 9, 2014 at 10:35 AM EDT in New York City. Lexicon management will provide an overview of Lexicon's clinical development programs and milestones.
Lexicon is a biopharmaceutical company focused on developing breakthrough treatments for human disease. Lexicon has clinical-stage drug programs for diabetes, carcinoid syndrome, and other indications, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets. For additional information about Lexicon and its programs, please visit www.lexpharma.com.
Safe Harbor Statement
This press release contains "forward-looking statements," including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to meet its capital requirements, successfully conduct preclinical and clinical development of its drug candidates, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE Lexicon Pharmaceuticals, Inc.
May. 31, 2016 07:45 AM EDT Reads: 1,620
May. 31, 2016 07:45 AM EDT Reads: 1,751
May. 31, 2016 07:30 AM EDT Reads: 833
May. 31, 2016 07:30 AM EDT Reads: 860
May. 31, 2016 07:00 AM EDT Reads: 836
May. 31, 2016 06:00 AM EDT Reads: 2,034
May. 31, 2016 05:45 AM EDT Reads: 1,194
May. 31, 2016 05:45 AM EDT Reads: 3,371
May. 31, 2016 05:00 AM EDT Reads: 3,374
May. 31, 2016 04:30 AM EDT Reads: 1,587
May. 31, 2016 04:15 AM EDT Reads: 2,117
May. 31, 2016 04:15 AM EDT Reads: 1,432
May. 31, 2016 04:15 AM EDT Reads: 3,075
In his session at 18th Cloud Expo, Bruce Swann, Senior Product Marketing Manager at Adobe, will discuss how the Adobe Marketing Cloud can help marketers embrace opportunities for personalized, relevant and real-time customer engagement across offline (direct mail, point of sale, call center) and digital (email, website, SMS, mobile apps, social networks, connected objects). Bruce Swann has more than 15 years of experience working with digital marketing disciplines like web analytics, social med...
May. 31, 2016 04:00 AM EDT Reads: 1,540
Designing IoT applications is complex, but deploying them in a scalable fashion is even more complex. A scalable, API first IaaS cloud is a good start, but in order to understand the various components specific to deploying IoT applications, one needs to understand the architecture of these applications and figure out how to scale these components independently. In his session at @ThingsExpo, Nara Rajagopalan is CEO of Accelerite, will discuss the fundamental architecture of IoT applications, ...
May. 31, 2016 04:00 AM EDT Reads: 1,438